Latest News

US FDA approves Abbott’s longer-length Esprit for severe PAD

The US Food and Drug Administration (FDA) has approved Abbott’s new longer-length Esprit BTK system for the treatment of chronic limb-threatening ischaemia (CLTI). The longer-length...

Features

Rethinking interventions for asymptomatic carotid stenosis

Caitlin Hicks (Baltimore, USA) reflects on CREST-2 following publication of the trial late last year. After nearly a decade of enrolment and follow-up, CREST-2 provides...

From the operating theatre to Westminster, PAD needs a unifying voice

In the first of a series of regular columns, Rachael Forsythe (Edinburgh, UK) provides an update from the Circulation Foundation—the UK’s only national charity...

Videos

Jamal Jawad Hoballah (American University of Beruit, Beruit, Lebanon) speaks to Vascular News on the sidelines of the 2026 Vascular Annual Meeting (VAM) about new research looking at the cost effectiveness of endovascular aneurysm repair (EVAR) vs open repair...

Most read

Features

Profiles

Kak Khee Yeung

Marianne Brodmann

Alik Farber